Table 5 Odds ratio of readmission and postoperative complications by CCI and polypharmacy in patients with hip or appendicular fracture
From: The impact of an orthogeriatric intervention in patients with fragility fractures: a cohort study
n (%) | Odds ratio of postoperative complications by CCI and polypharmacy in patients with hip or appendicular fracture | Odds ratio of readmission by CCI and polypharmacy in patients with hip or appendicular fracture | |||
|---|---|---|---|---|---|
OR (95% CI) | P-value* | OR (95% CI) | P-value* | ||
Hip (n = 395) | |||||
Polypharmacy | 267 (67.6) | 0.80 (0.51–1.24) | 0.32 | 1.92 (1.02–3.60) | 0.04 |
Charlson Comorbidity Index | |||||
0 | 124 (31.4) | 1 | 1 | ||
1 | 89 (22.5) | 1.12 (/0.66–1.90) | 0.68 | 1.29 (0.62–2.70) | 0.50 |
≥2 | 182 (46.1) | 1.45 (0.93–2.28) | 0.10 | 1.21 (0.62–2.70) | 0.56 |
Appendicular fracture (n = 196) | |||||
Polypharmacy | 99 (50.5) | 0.84 (0.31–2.28) | 0.73 | 2.38 (0.60–9.5) | 0.22 |
Charlson Comorbidity Index | |||||
0 | 91 (46.4) | 1 | 1 | ||
1 | 51 (26.0) | 1.52 (0.44–5.26) | 0.51 | 1.8 (0.25–13.30) | 0.56 |
≥ 2 | 54 (27.6) | 1.79 (0.54–5.85) | 0.34 | 5.6 (1.10–26.63) | 0.04 |